InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
-2.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Slamon Dennis, Director. Officer active across 1 company, notably Biomarin Pharmaceutical INC. In total, 6 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €407k. History available since 25 May 2021. The latest transaction was disclosed on 18 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
10,000 shares@ US$79.7064.3% of flowCommon StockSEC:0001048477-24-000052:0
4,190 shares0Common StockSEC:0001209191-23-031978:0
4,980 shares0Common StockSEC:0001567619-22-011802:0
5,815 shares@ US$78.330.0036% mcap100.0% of flowCommon StockSEC:0001567619-22-006092:0
5,120 shares0Common StockSEC:0001567619-21-011326:0
5,120 shares0Common StockSEC:0001567619-21-011326
6 of 6 declarations
About Slamon Dennis
Slamon Dennis is a Board Member at BIOMARIN PHARMACEUTICAL INC. He contributes to the strategic direction of the company and oversees its operations, bringing his experience in the pharmaceutical sector.
